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ANALYSIS OF KETAMINE AND XYLAZINE IN FUR AND BONES USING 
MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY TANDEM MASS 
SPECTROMETRY 
 
 
NEESHA CLAIRE KARANTH 
 
ABSTRACT 
While ketamine is traditionally administered for anesthesia or pain 
management, illicit usage is often seen in forensic cases either as a recreational 
drug or as a tool in drug-facilitated sexual assault. Xylazine is an anesthetic 
agent used in veterinary medicine and does not have FDA approval for use in 
humans. However, it has recently been observed as a cutting agent in heroin. 
Post-mortem specimens present many challenges when it comes to toxicological 
analysis. Due to compound degradation and decomposition factors, analytes 
present at trace levels may be missed in blood and urine. Hair, bone, and insects 
have recently been investigated as alternative matrices for postmortem analysis 
due to their increased durability compared to more traditional matrices. However, 
this durability increases the difficulties in extracting and isolating compounds of 
interest from these matrices via traditional extraction and chromatography 
methods. These methods require lengthy extraction times and extensive cleanup 
steps in order to obtain samples suitable for analysis. Utilizing multiple 
instrumentation combinations, analysts are able to detect compounds at trace 
levels. Through the use of multidimensional chromatography, several time-
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consuming extraction steps can be eliminated while still retaining the ability of 
trace level detection and quantitation. Using Waters Oasis® HLB PRiME solid 
phase extraction cartridges using a methanol pH10 loading and an acetonitrile  
pH3 elution, a solvent extraction yielded linear dynamic ranges of 2pg/mL-
1ng/mL and 5pg/mL-1ng/mL for xylazine and ketamine respectively.  
 Rat specimens utilized in this project were treated as per an Institutional 
Animal Care and Use Committee (IACUC) protocol. The test rodents received an 
acute dosage of 2mg/mL of xylazine and 24mg/mL of ketamine approximately 
half an hour prior to death. The 14 test samples were placed outside directly on 
the ground at the Boston University Forensic Anthropology Outdoor Research 
Facility (Holliston, MA, U.S.A.) for a period of 6 months. A 15th rat was kept in -
20°C until analysis to serve as a Time=0 sample. The outdoor samples were 
recovered and de-fleshed along with the Time=0 sample manually. 
Drug-free hair samples were donated anonymously as per Internal Review 
Board (IRB) protocols.  
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1. INTRODUCTION 
 
1.1 Postmortem Toxicology 
1.1.1 Current sample matrices 
Toxicology involves the detection and/or quantification of drugs or poisons 
within a biological matrix. Postmortem toxicology focuses on the testing of 
samples from deceased individuals. Certain matrices such as blood, urine, soft 
tissue, vitreous humor, and oral fluid are most commonly used due to 
accessibility and ease of analysis. This is due to the fact that, with the exception 
of soft tissue, these samples are liquids, requiring significantly less sample 
preparation prior to analysis. In an ideal scenario, these samples are collected at 
autopsy soon after death with minimal exposure to external contaminants. In 
addition, there is a sufficient quantity of each matrix from which samples can be 
acquired from multiple locations with clean collection methods and containers[1]. 
In order to isolate substances that are inconsistent with that individual’s typical 
medications and environmental exposure, forensic toxicologists use the 
deceased individual’s medical history, collected by medico-legal death 
investigators. This information, along with case findings, is influential in 
determining screening methods and identifying which analytes are important for 
subsequent analysis.    
1.1.2 Complications with traditional matrices 
Death brings complications of decomposition factors and drug 
degradation. Unlike with clinical toxicology, there is a finite supply of different 
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matrices in the deceased, depending on the many factors influencing 
decomposition. Care must be taken to reduce contamination and ensure an 
adequate supply for immediate and future testing. Autolysis and bacterial 
decomposition begin almost immediately after death, compromising the integrity 
of the biological fluids and potentially the drugs within these biological matrices. 
Postmortem redistribution, for example, is the result of observing inconsistent 
concentrations of a xenobiotic substance from samples taken from different 
locations. Depending on the drug and body composition, there can be significant 
differences in concentrations from blood taken from the heart versus blood taken 
from peripheral extremities[2]. The degree of drug degradation is dependent on a 
number of factors: the type of drug, the drug’s pharmacokinetic and 
pharmacodynamic properties, exposure to additional chemicals, environmental 
conditions, and postmortem interval[1]. For example, drugs or toxins in a corpse 
exposed to high temperatures in a dry environment can have different 
concentrations than those in a corpse exposed to low temperatures in a wet 
environment, even if they started with identical perimortem drug concentrations.  
Embalmed and interred remains pose a problem in that traditional 
matrices are either removed or too degraded for use in typical analytical 
methods. Some examples include “cold” cases, or cases in which the original 
cause and manner of death are called into question. Alternative matrices are 
considered more stable, so they are still suitable for analysis once an optimal 
analytical method has been developed.  
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1.2 Alternative Matrices 
1.2.1 Hair 
 Hair is a collection of keratinized cells that are fused together to form 
strands. Those strands are formed in hair follicles found over the skin’s surface. 
Hair structure contains three layers:  the cortex, the medulla, and the cuticle.  
 
Figure 1: Hair follicle cross-section[3] 
Xenobiotics are incorporated into the hair through two processes:  the primary 
mechanism during root formation through attachment to the medulla and the 
secondary mechanism when the drugs enter the cuticle and disperse through the 
hair[4]. The primary mechanism occurs at the hair papilla inside the hair bulb. 
The hair papilla is vascularized, as seen in Figure 1, so drugs inside the blood 
are integrated within the hair matrix. The secondary mechanism occurs during 
external deposition of drugs onto the cuticle and their subsequent diffusion into 
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the hair. Factors that influence the amount and rate of disposition include 
surrounding enzyme activity, rate of hair growth, and drug type and dosage.  
There are many factors that affect the long-term stability of hair for use as 
a toxicological matrix. Ultra violet radiation, heat, and cosmetic chemical 
treatments are the major contributors to reduction in drug concentrations in 
hair[5–7]; exposure to any of these conditions should be recorded by law 
enforcement or medicolegal death investigators, if possible. Storage conditions 
should also ensure protection from those factors. The Society of Hair Testing’s 
Consensus on Hair Analysis states that hair samples should be stored dry, in the 
dark, and at room temperature[8].  These conditions do not require additional 
equipment or resources, so this is easier for laboratories with limited space or 
budgets, both problems commonly faced by public testing labs. 
Aside from post-mortem examinations, hair analysis can also be utilized in 
cases such as workplace drug testing, child custody disputes involving parental 
drug abuse, and drug-facilitated sexual assaults (DFSA). Due to delayed 
reporting of DFSAs, incapacitating drugs may not be present in blood or urine 
during examination, which are the typical toxicological specimens taken in a 
sexual assault kit. However, the Sexual Assault Nurse Examiner also collects 
hair samples; these are typically used for trace analysis and fiber comparisons. 
As a toxicological matrix, hair has a longer window of detection as opposed to 
blood and urine. Using hair as an alternative testing material in sexual assault 
cases can provide evidence of drug administration for months after the fact. 
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1.2.2 Bones 
 The skeletal system is comprised of cartilage and rigid calcified organs 
known as bones. The skeletal system “supports the body, facilitates movement, 
protects internal organs, produces blood cells, and stores and releases minerals 
and fat.”[3] Bones are classified as “a hard, dense connective tissue”[3] 
comprising of cortical bone, cancellous bone, and bone marrow. Cortical, or 
compact bone is the solid outer layer of the bone, providing shape and structural 
support. Cancellous, or spongy bone is similar to honeycomb in appearance, and 
is typically located at the ends of long bones, inside vertebrae, and at load-
bearing joints[3]. Figure 2 illustrates typical bone structure. These characteristics 
are harder to view in other types of bone due to their different shapes and 
functions. 
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Figure 2: Gross bone anatomy and cross-section[3] 
 
There are four different types of cells within bone: osteogenic cells, 
osteoblasts, osteocytes, and osteoclasts[3]. All of these cells have access to 
blood vessels that enter the bone through nutrient foramina, small holes in the 
bone’s surface, into the osteon system (Figure 3). These vessels run through the 
bone shaft via Haversian, or central canals located in the center of each osteon, 
and nutrients are distributed to the osteoblasts and osteocytes through 
Volkmann’s, or perforating canals[3].  
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Figure 3: Osteon system cross-section[3] 
There is constant activity by all the bone cells, so substances circulating in 
the blood are incorporated into the bone tissue by osteocytes and osteoblasts. In 
addition, if the bones have maintained their structural integrity, water-soluble 
compounds would most likely be found within red marrow, and fat-soluble 
compounds would be stored within yellow marrow. 
As a toxicological matrix, bone is effective because it can be stored for 
long term without requiring refrigeration or freezing to maintain viability. In cases 
where the body is significantly decomposed, bone may be the only toxicological 
sample available.   
1.2.3 Complications with alternative matrices 
The attributes that help hair and bone samples retain their stability also 
pose issues for extraction and analysis. With both matrices, the extraction 
process begins with either the sample being mechanically broken down into 
smaller pieces. This increases the surface area of sample exposed to future 
8 
extraction steps, allowing access to internal components such as marrow or the 
medulla where drugs are also incorporated. Examples in the literature include 
scissors[9], pliers[10], domestic grinders[11], and a mortar and pestle[11], which 
can be effective, but bead mills are preferred due to their ability to rapidly 
breakdown solid material into minute particles [9] rather than the larger fragments 
produced by the previous methods. Particular care must be taken with hair 
because the strands are susceptible to static charge and air movement, 
especially in cases with small sample sizes. 
After the sample has been separated into smaller pieces, the analyte of 
interest will direct the reagents used for extraction; in cases where the history is 
unknown, these must be carefully considered. Common extraction techniques 
involve acidic or basic digestion, solvent extraction, heated incubation, or 
enzymatic hydrolysis[9]; if the analyte of interest is unstable in any of those 
conditions, any trace of it will be lost or rendered undetectable.  
In addition, the matrix itself can have inconsistencies that can complicate 
analysis. For instance, hair pigmentation levels play a role in the concentration of 
drugs incorporated into hair; individuals with increased melanin production will 
have an increased drug concentration than individuals with less melanin, even if 
they are taking the same dosages[12]. With bone, surface contamination from 
surface decomposition can enhance or reduce drug concentrations[10]. 
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1.3 Ketamine and Analysis in Toxicology Labs 
1.3.1 Mechanism of action and appearance in casework 
Ketamine is an arylcyclohexamine used in both human and veterinary 
medicine for its sedative and analgesic effects. Arylcyclohexamines act as N-
methyl-D-aspartate (NMDA) antagonists and as dopamine D2 receptors agonists 
in the brain[13].  
 
 
Figure 4: Ketamine Molecular Structure[14] 
 
Arylcyclohexamines have anticonvulsant, dissociative, and anesthetic properties, 
which lend themselves to a variety of pharmacological applications[13]. Due to 
the variety of functional groups present, those effects can vary in type and 
severity from compound to compound; for example, ketamine and phencyclidine 
have similar dissociative effects, but ketamine’s are shorter in duration and less 
intense than phencyclidine. Ketamine induces tranquilizing and dissociative 
effects upon administration, and in addition to sedation and pain relief, individuals 
will total amnesia [15]. 
10 
 The Food and Drug Administration (FDA) has approved Ketamine for both 
human and veterinary uses. Clinical uses for ketamine include inducing 
dissociative sedation and analgesia for shortened procedures or to reduce stress 
to a patient during a potentially traumatizing procedure or exam. 
The Controlled Substances Act classifies ketamine as a Schedule III drug 
for due to its medical uses with some potential for abuse[16]. As such, the Drug 
Enforcement Administration (DEA) compiles reported cases in the National 
Forensic Library Information System (NFLIS) under the tranquilizers and 
depressants category[17]. The 2017 NFLIS-Drug 2017 Midyear Report has 731 
reported cases involving ketamine nationwide, an increase of 3.4% from the 
2016 NFLIS-Drug Midyear report, and 58.6% of the total ketamine cases 
reported in 2016[17–19]. Ketamine is most often seen in club settings, going by 
the street names of “Special K”, “K”, and “Kit Kat”, and the dissociative effects 
are referred to as a “K-Hole”[16].  
Due to its ability to induce a catatonic state in conjunction with total 
amnesia, ketamine is frequently seen in DFSA cases. This can be through 
consensual or nonconsensual administration. In 2015, The Washington Post and 
the Kaiser Family Foundation conducted a survey of current college students and 
recent graduates; 14% of women and 4% of men surveyed reported DFSA when 
answering the questions posed[20] . While there is little information on the 
breakdown of which drugs are present in DFSA case, it is important when 
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interviewing victims to ask if they can recall any symptoms and if so, what they 
were. This can provide guidelines for screening tests.  
1.3.2 Current analytical techniques 
There is currently a multidimensional liquid chromatography tandem mass 
spectrometry method for ketamine in rat tissue yielding limits of detection of 
0.5pg/mL [21], utilizing mixed-mode cation exchange(MCX) solid phase 
extraction(SPE) for sample preparation. The most commonly used methods are 
High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) or 
Ultra Performance Liquid Chromatography Tandem Mass Spectrometry (UPLC-
MS/MS)[11,22–24]. Limits of detections for those studies range from 
0.02ng/mL[23] to 5ng/mL[11], using SPE for sample preparation of the hair and 
bone samples. In the Watterson study, further research into whether the body 
incorporated more ketamine in cancellous or cortical bone, and if marrow residue 
introduced a potential contamination issue. Baretto et al’s method involved an 
extensive washing process prior to sample preparation and extraction including 
an hour long drying cycle. 
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1.4 Xylazine and Analysis in Toxicology Labs 
  
Figure 5: Xylazine Molecular Structure[25] 
 
1.4.1 Mechanism of action and appearance in casework 
Xylazine is a veterinary anesthetic agent often administered in conjunction 
with ketamine. It acts as an α-2 andrenergenic agonist to produce sedation and 
analgesia during veterinary procedures[26,27]. In addition, side effects include 
bradycardia, respiratory depression, muscle relaxation, and central nervous 
system depression. However, it is unclear how xylazine interacts with the human 
body to create these symptoms because there is little research on its mechanism 
of action. Clinical trials for use in humans were halted due to severe hypotension 
that occurred[28], so the FDA has only approved it for veterinary use.  
Because xylazine is not approved for human use, it is not a controlled 
substance. This means there is no case data reported to NFLIS; however, there 
have been case reports in the literature involving xylazine overdoses. For 
example, in Puerto Rico, xylazine was observed to be an adulterant in both 
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heroin and cocaine samples, which resulted in fatal and non-fatal 
overdoses[29,30]. This is most likely the result of dealers increasing the amount 
of product they can sell by supplementing their product with a drug that induces 
similar effects. 
1.4.2 Current analytical techniques  
Because it is not a controlled substance, it is unlikely that many forensic 
toxicology departments have pre-established methods for detecting xylazine in 
case samples. However, veterinary pharmacological research has resulted in 
quantitative methods in whole blood samples using liquid-liquid extraction (LLE) 
and either HPLC-MS or UPLC-MS-MS[26–28]. Testing on tissue and postmortem 
blood have yielded limits of detection of 1ng/mL, 2.81ng/mL, and 5.1[28,31,32] in 
humans, which is well above the trace levels necessary for bone and hair 
analysis. However, there is limited case history on the dosage consumed or 
decomposition period, so those factors may have influenced how much entered 
those matrices. It is recommended that multiple screening methods should be 
employed in clinical settings due to the rarity of its appearance. 
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1.5 Instrumentation Theory  
1.5.1 Single-dimension liquid chromatography-tandem mass spectrometry 
 Liquid chromatography is the separation of compounds by dissolving them 
into a liquid mobile phase and interacting with a solid stationary phase based on 
their chemical properties in order to reach a detector at different retention times.  
 
Figure 6: LC-MS schematic  
Liquid chromatography uses a liquid mobile phase facilitate the movement of 
compounds through the column into the detector. Water and an organic solvent 
such as methanol or acetonitrile are the most commonly used mobile phase 
combinations. These mobile phases can be pH-adjusted to improve the 
separation of compounds and reduce the effects of ion suppression or 
enhancement once the compound reaches the detector[33]. 
Single-dimensional liquid chromatography-tandem mass spectrometry, or 
HPLC-MS and UPLC-MS/MS, refers to the utilization of a single analytical 
column for the separation of compounds. Two common chromatographic 
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techniques include hydrophilic interaction liquid chromatography (HILIC), a type 
of normal phase chromatography, or reverse phase chromatography. With HILIC 
methods, the analytical column contains a stationary phase that is more polar 
than the mobile phase, which results in a stronger retention of hydrophilic 
compounds in the sample[34]. The stationary phase will consist of either silica 
particles with no attached functional groups or with polar molecules such as 
amino, cyano, or amide groups attached to form a hybrid stationary phase. 
Reverse-phase chromatography utilizes a non-polar stationary phase in 
conjunction with a polar solvent. Typical results include shorter retention times for 
polar compounds than non-polar compounds due to their different affinity towards 
the mobile phase[35]. The reverse-phase columns are packed with silica 
particles with a carbon-based ligand that varies based on the compounds of 
interest. An example of a common ligand is C18, which is an eighteen carbon 
chain, which is bonded to the silica particle[36]. Because C18 interacts with a 
large variety of compounds, it is typically the first column chemistry of choice 
when developing a method. Other ligands include C4, C8, phenyl, and fluoro, 
which have different degrees of selectivity for compounds. During method 
validation, multiple different columns are evaluated to discover optimal 
separation conditions for the analytes of interest.  
Columns are selected based on the following criteria: length, internal 
diameter, particle size, and chemistry. The internal diameter of the column 
determines the pressure within the column as the mobile phase travels through it. 
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Particle size refers to the size of the materials that make up the stationary phase. 
The Van Deemter equation represents the relationship between eddy diffusion, 
longitudinal diffusion, and interphase mass transfer, which are impacted by both 
particle size and internal diameter[37]. Eddy diffusion describes the pathways an 
analyte can travel through the analytical column; the longer the analyte travels, 
the longer the retention time. Eddy diffusion is controlled by stationary phase 
particle size and the how compact those particles are pressed within the column. 
Longitudinal diffusion refers to the spread of the compound of interest from high 
to low areas of concentration, and is controlled by the mobile phase’s type, flow 
rate, and viscosity as it moves through the circuit. Interphase mass transfer is 
related to the equilibration time required for a particle to stabilize between the 
stationary and mobile phases.  Smaller particle sizes reduce the peak 
broadening caused by increased eddy diffusion,	   increasing resolution and 
sensitivity. However, smaller particle sizes also result in increased pressure, 
which can negatively affect interphase mass transfer, which must be considered 
when choosing a technique[35]. For example, HPLC typically uses particle sizes 
of 3.5µm to 5µm, which can handle up to 6000 pounds per square inch, or psi, 
while UPLC will use particle sizes of 1.75μm to 2.5μm and can take up to 
18,000psi. If sensitivity is not a priority, then a larger particle size is suitable, 
whereas in samples with trace amounts, a smaller particle size is required. 
Column chemistry is determined by the type of stationary phase packed within 
the column. Methods for detecting drugs of abuse most commonly use reverse-
17 
phase chromatography due to their lower molecular weight, and polarity[36]. 
Typical drugs of interest such as cocaine and ketamine are water soluble and 
more polar, which results in shorter retention times in reverse phase 
chromatography. 
1.5.2 Multidimensional chromatography 
 While multidimensional chromatography utilizes the general concepts 
behind traditional liquid chromatography, it incorporates two additional elements 
to improve separation, resolution, and sensitivity. First, it adds an additional 
column chemistry contained in a trap column, which is located after the sample 
manager but before the analytical column. Secondly, multiple pumps are added 
to the instrumentation configuration to increase sensitivity and improve 
resolution. This experiment utilized a trap-and-elute two-dimensional set-up as 
shown in Figure 7. 
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Figure 7: 2D-LC system configuration[38] 
In a trap-and-elute scenario, there is a valve in the column manager 
separating the trap column and the analytical column. When the system is in trap 
mode, the valve closes to prevent mobile phase from reaching the analytical 
column. The sample, made up entirely of organic solvent enters the fluid circuit at 
this point and is loaded onto the trap column. There, additional aqueous mobile 
phase flows from the dilutor line to mix with the sample at the mixer in a process 
known as at-column dilution. This increases the sample volume and creates an 
organic/aqueous sample mixture to prevent breakthrough on the analytical 
column. Once the sample has been sufficiently diluted, the column manager 
valve opens, allowing the sample to enter the analytical column. By increasing 
the sample volume, this increases the amount of analyte being injected into the 
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system, allowing for lower limits of detection and quantitation. The at-column 
dilution process improves sensitivity because it allows for the injection of a larger 
organic sample volume, which increases sensitivity while also reducing sample 
preparation time. This is achieved by eliminating the reconstitution step of 
sample preparation, which ranges from hours to overnight evaporation.  
1.5.3 Comparison of sample preparation methods for single dimensional and 
multidimensional chromatography 
 While there are some similarities between sample preparation methods for 
traditional single dimensional and multidimensional chromatography, there is a 
key difference, which allows for the increased	  sensitivity. That difference is the 
sample composition when it is injected into the chromatographic system. In order 
for effective retention on the analytical column, a sample must be a mixture of 
aqueous and organic solvents. When a 100% organic sample is injected onto an 
analytical column, it does not interact with the analytical column’s stationary 
phase. This lack of interaction causes the sample to be eluted at the initial stages 
of the chromatographic run, rather than during the gradient. This phenomenon, 
known as breakthrough, drastically reduces the method’s specificity due to 
insufficient time for multiple analytes within the sample to interact with the 
stationary phase. Each analyte will pass through an analytical column at different 
rates due to their increased or decreased retention on the stationary phase, 
which is exhibited by their different retention times. To prevent breakthrough, 
traditional HPLC or UPLC sample preparation methods require that an organic 
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eluent from a sample preparation scenario be evaporated to dryness to remove 
all of the organic solvent and subsequently reconstituted with a 95:5 mixture of 
the aqueous and organic mobile phased used in the analytical method. This 
process can be time-consuming, either in the form of allowing the solvent to 
passively evaporated, or accelerating the process with an evaporator or heating 
block, which can still take hours. This reduces the time available for sample 
analysis and preparation of additional samples. Once a sample is reconstituted, 
only a small amount can be injected into the system, to prevent any possibilities 
of breakthrough. The small injection volume reduces the likelihood that an 
accurate representation of the sample has made it into the system, diminishing 
the absolute confidence in one’s results. 
 Conversely, the at-column dilution method utilized in multidimensional 
chromatography eliminates the reconstitution stage of sample preparation 
entirely. This is because the organic eluent is mixed with water at the mixer 
rather than after the sample has been dried and reconstituted with an organic 
and aqueous mixture prior to injection. This allows for an increased injection 
volume, which improves the likelihood that all analytes present in the sample are 
represented in the injection. In addition, the increased injection volume increases 
sensitivity by allowing more sample to reach the detector.   
  A method’s analytical parameters can be created from hundreds of 
combinations, including mobile phases, pH, and column chemistries. By using a 
6x6 grid to test 36 combinations of those characteristics, a wide range of possible 
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methods can be tested to inform future steps. When combined with automation, 
those can be evaluated overnight to increase productivity during working hours. 
An analyte’s pKa will affect its ionization state at different pHs, which in turn 
effects how it interacts with both the stationary and mobile phases. For example, 
ketamine has a pKa of 7.5, which means that it would be ionized at low pH values 
and neutral at high pH values. By testing a range loading pHs, the analyte’s 
interaction with the trap column’s stationary phase can be enhanced or hindered 
by whether the compound of interest is in an ionized or neutral state. This testing 
scheme can also be applied to the elution solvent to determine the optimal pH for 
analysis. The trap column sorbents range from C8, which has the lowest retention 
strength, to HLB, which has the highest retention strength. The retention strength 
can increase or decrease the retention time in order to keep it within the gradient. 
By observing the chromatograms from the 36 methods, a choice can be made for 
method development going forward. 
1.6 Research Objective 
 This research hopes to determine whether or not an acute dosage of both 
ketamine and xylazine can be detected in bone and fur samples following six 
months of decomposition using 2D-LC/MS/MS technologies, which will be 
coupled with accelerated extraction methods to facilitate trace-level detection at 
points per trillion (ppt)  
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2. MATERIALS AND METHODS 
2.1 Instrumentation 
 Compound optimization and chromatography method development were 
performed using Waters ACQUITY UPLC® QSM, BSM, FTN Sample Manager, 
Column Manager, and Xevo TQ-S tandem mass spectrometer (Waters 
Corporation, Milford, MA, USA). MassLynx© version 4.1 (Waters Corporation, 
Milford, MA, U.S.A.) software was used to control instrumentation, view 
chromatograms and spectra, and monitor instrumentation conditions. 
2.2 Standards and Reagents 
 Analytical reference standards for ketamine and ketamine-D4, were 
obtained from Cerilliant© (Round Rock, TX, U.S.A.) in the form of 1mg/mL 
solution dissolved in methanol for ketamine and 100µg/mL solution dissolved in 
methanol for ketamine-D4. 
 Xylazine was obtained from Cayman Chemicals© (Ann Arbor, MI, U.S.A.) 
in powder form and mixed into solution using Optima™ grade methanol.  
 Xylazine-D6 was obtained from Frontier Biopharm© (Richmond, KY, 
U.S.A.) in powder form and mixed into solution using Optima™ grade Methanol.  
 Optima™ grade methanol, acetonitrile, hexane, acetone, water, and 
isopropanol were obtained from Fisher Scientific™ (Waltham, MA, U.S.A.) 
Formic acid of 99% purity, ammonium hydroxide, and hydrochloric acid were 
obtained from Millipore Sigma© (St. Louis, MO, U.S.A.). 
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 AQCUITY UPLC BEH C18 analytical column, 130Å, 1.7µm 2.1mm X 
50mm and AQCUITY UPLC BEH C18 VanGuard Pre-column, 130Å, 1.7µm 
2.1mm X 30mm guard columns were obtained from Waters Corporation (Milford, 
MA, U.S.A.). XBridge BEH C18 Direct Connect HP Column, 130Å, 10 µm, 2.1 
mm X 30 mm, XBridge BEH C8 Direct Connect HP Column, 130Å, 10 µm, 2.1 
mm X 30 mm, and XBridge BEH HLB Direct Connect HP Column, 130Å, 10 µm, 
2.1 mm X 30 mm were acquired from Waters Corporation (Milford, MA, U.S.A.). 
Oasis® HLB, HLB PRiME, and MCX solid phase extraction cartridges 
were obtained from Waters Corporation in 3cc/60mg, 6cc/150mg, and 
6cc/200mg sizes (Milford, MA, U.S.A.). Chrom Tech® centrifuge filter tubes, MIDI 
PFTE 0.45µm, were obtained from Chrom Tech®(Apple Valley, MN, U.S.A). 
Vivaspin® 6 centrifuge filter tubes were acquired from Sartorius (Goettingen, 
Germany).  
Ultrapure water was obtained using a Milli-Q® IQ 7000 water purification 
system with a LC-Pak® Polisher filter attachment purchased from rom Millipore 
Sigma© (St. Louis, MO, U.S.A.). 
A Precellys Evolution homogenizer equipped with a 15mL holder pack 
was used to homogenize the bone and hair samples in 15mL extraction tubes 
with 4 ceramic ball bearings from Bertin Corporation (Rockville, MD, U.S.A).  
2.3 Rats and Hair 
 The hair used for method development was donated by an anonymous 
donor as per IRB protocol.  
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The rats were obtained from the Boston University Animal Science Center 
(Boston, MA, U.S.A.). They were dosed with 2mg/mL of xylazine and 24mg/mL of 
ketamine prior to euthanasia. Fourteen of the fifteen rats procured were placed 
outside at the Boston University Forensic Anthropology Outdoor Research 
Facility (Holliston, MA, U.S.A.) for a period of six months. They were placed 
directly on the ground and secured using a wire mesh screen (Figure 8).  
 
Figure 8: Rat specimens at (L-R): initial deposition, 3 months, and 6 months  
After six months, the rats were removed from the site, and any remaining 
fur or bones in addition to the skeletal remains were collected and placed into -
20°C storage. The fifteenth rat was kept at -20°C to act as a Time:0 sample. 
Flesh, grass, insects, and fur were then removed manually from each skeleton. 
2.4 Method Development 
2.4.1 Compound optimization 
Compound optimization was conducted by performing multiple reaction 
monitoring (MRM) for both ketamine and xylazine and evaluating the effects of 
different pH, electrospray charge, collision energy, cone voltage, and solvents 
had on signal strength. Each compound was directly infused into the mass 
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spectrometer; the infusion solution consisted of a 10ppb standard concentration 
in a 50:50 methanol:water solution. The different pH evaluations were done by 
adding formic acid, ammonium hydroxide, or neither additive. The infusion 
samples were run using MS1 mode to determine the precursor ion; the cone 
voltage and probe position were varied in order to produce the most intense 
signal. The product ions were determined using MS/MS mode with multiple 
collision energies evaluated. This determines the different product ions created at 
the different collision energies; there is increased molecule fragmentation when 
the collision energy becomes higher. The quantitative and qualitative ions were 
chosen based on the 2 fragments with the highest signal intensities. For MRM 
conditions, the collision energies that produced the highest signal were selected 
for that specific ion. The experimental values are listed in Table 1. 
Table 1: Compound MRM Values acquired on Xevo TQ-S 
Compound Ion Mode Precursor 
Ion 
Cone 
Voltage 
Product 
Ions 
Collision 
Energy 
Ketamine ESI+ 238.2 30 125.0 25 
222.2 15 
Ketamine-
D4 
ESI+ 242.2 30 129.1 25 
224.2 10 
Xylazine ESI+ 221.2 30 90.1 20 
164.0 20 
Xylazine-
D6 
ESI+ 227.2 30 90.2 20 
170.1 25 
 
2.4.2 Chromatography optimization 
36 LC methods were evaluated to determine the optimal conditions for the 
analysis of both ketamine and xylazine. This was done by testing different 
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combinations of solvent types, pH, and trap column sorbent. The grid with the 36 
permutations appears in two parts in Tables 2 and 3. 
 
Table 2: Acetonitrile Chromatography Evaluation Parameters 
 Water/Solvent Water Trap Column Chemistry 
Solvent 
Type Elution pH 
Loader/Diluter 
pH C8 C18 HLB 
Acetonitrile 
pH10 
pH 10 16 17 18 
pH 7 13 14 15 
pH 3 10 11 12 
pH 3 
pH 10 7 8 9 
pH 7 4 5 6 
pH 3 1 2 3 
 
 
Table 3: Methanol Chromatography Evaluation Parameters 
 Water/Solvent Water Trap Column Chemistry 
Solvent 
Type Elution pH 
Loader/Diluter 
pH C8 C18 HLB 
Methanol 
pH10 
pH 10 34 35 36 
pH 7 31 32 33 
pH 3 28 29 30 
pH 3 
pH 10 25 26 27 
pH 7 22 23 24 
pH 3 19 20 21 
 
The flow rates, column manager temperature, sample manager temperature, and 
MRMs were kept the same for each method. Each method was tested using 
10ng/mL concentrations of ketamine and xylazine in water, methanol, and 
acetonitrile; injections were performed in triplicate for each solvent.  
Chromatograms for each method were evaluated based on peak shape, signal 
strength, and retention time; each method was assigned a color designation of 
red, yellow, or green, from green representing optimal signal recordings – 
defined here as Gaussian peak shapes with at least an e6 signal intensity - to red 
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representing no signal present. Methods 1-9 involved eluting with a 5-95% 
acetonitrile ph3 gradient, while Figure 9 provides representative peaks from each 
method. 
 
Figure 9: Xylazine Chromatograms, Methods 1-9 
 
Table 4: 3X9 Chromatography Evaluation for each compound, Eluting with 
Acetonitrile, pH3 
 Method 1 2 3 4 5 6 7 8 9 
 Column C8 C18 HLB C8 C18 HLB C8 C18 HLB 
 
Loading 
pH pH3 pH3 pH3 pH7 pH7 pH7 pH10 pH10 pH10 
Solvent Eluting pH pH3 pH3 pH3 pH3 pH3 pH3 pH3 pH3 pH3 
Water 
Ketamine e7 4.35 
e7 
4.55 
e7 
4.34   
e6 
4.65 
lead 
e7 
4.33 
e7 
4.30 
e7 
4.50 
e7 
4.33 
Xylazine e7 4.48 
e6 
4.71 
e7 
4.46   
e6 
4.65 
split 
e7 
4.45 
e7 
4.42 
e7 
4.65 
e7 
4.45 
MeOH 
Ketamine e7 4.36 
e7 
4.55 
e7 
4.35 
e4 
4.28 
split 
e6 
4.65 
lead 
e7 
4.33 
e7 
4.31 
e7 
4.50 
e7 
4.33 
Xylazine e7 4.48 
e7 
4.71 
e7 
4.46 
e5 
4.41 
split 
e6 
4.84 
split 
e7 
4.45 
e7 
4.42 
e7 
4.65 
e7 
4.45 
ACN 
Ketamine e7 4.35 
e7 
4.55 
tail 
e7 
4.35 
e4 
4.30 
split 
e6 
4.62 
lead 
e7 
4.33 
e7 
4.31 
e7 
4.50 
e7 
4.33 
Xylazine e7 4.48 
e7 
4.71 
tail 
e7 
4.46 
e5 
4.41 
split 
e6 
4.79 
split 
e7 
4.45 
e7 
4.43 
e7 
4.65 
e7 
4.45 
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After evaluating the peak shapes and signals, Method 6 was determined to be 
the final method. 
 During extraction evaluation, it became apparent that there was a 
carryover issue involving both compounds, even with running solvent blanks 
between each sample set (Figure 10).  
 
Figure 10: Old method carryover study 
The cause of these issues was determined to be insufficient cleaning of the mixer 
connecting the loader and diluter lines to the column manager. To resolve this, a 
reconditioning method resulting in changes to loader flow rate, solvent type, and 
gradient duration was added. In addition, 6 injections from a hexane blank were 
added between each sample set to flush out the system and remove any 
potential contamination. This was done by priming the loader line first with a 
1:1:1 Isopropanol:Acetonitrile:Acetone mixture with 2% formic acid for 10 minutes 
at 2ml/min for three blank hexane injections, and then followed by two blank 
hexane injections during which the line was primed with Milli-Q® water for 10 
minutes. The same was repeated with the dilutor pump, but instead of 1:1:1 
Isopropanol:Acetonitrile:Acetone mixture with 2% formic acid, it was flushed with 
a 1:1:1 Isopropanol:Acetonitrile:Acetone mixture with no addition. Finally, the 
final elution method was run to determine the presence of carryover.  
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 A reconditioning step was also added within the run itself to further reduce 
carryover of analytes from one sample to the next. Using the same 1:1:1 
Isopropanol:Acetonitrile:Acetone mixture with 2% formic acid, the loader line was 
flushed out for 2 minutes at 2mL/min after the gradient was completed. 
The gradient was reduced from five minutes to three minutes to accommodate 
the additional step without increasing the overall run time. This successfully 
removed the carryover, even when following the highest concentration calibrator, 
as seen in Figure 11: 
 
Figure 11: New method carryover study 
The final run conditions are listed below, compared to a typical run 
scenario: 
Table 5: Run condition comparison 
Carryover Reduction Run Conditions Typical Run Conditions 
1) Loading onto trap column: 3 minutes 
1) Loading onto trap column: 3 
minutes 
2) 5%-95% ACN gradient: 3 minutes 
2) 5%-95% ACN gradient: 5 minutes 
3) Hold at 95%ACN: 1 minute 
4) Flush out loader circuit with 1:1:1 
Acetone:Acetonitrile:Isopropanol with 
2% Formic Acid: 2 minutes 3) Hold at 95%ACN: 1 ½ minutes 
5) Flush out loader circuit with water, no 
addition: 1 ½ minutes 
6) Return to initial conditions: 30 
seconds 
4) Return to initial conditions: 30 
seconds 
Total Run Time: 10 minutes Total Run Time: 10 minutes 
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2.4.3 Extraction evaluation 
 Three different solid phase extraction cartridges were evaluated for 
extraction.  Waters Oasis® HLB, Oasis® PRiME HLB, and Oasis® MCX 
extraction cartridges were used. Each cartridge type was 3cc capacity with a 
60mg sized sorbent bed, through which 2mL water samples were passed at a 
concentration of either 1ppb or 10ppb, depending on the cartridge. HLB and 
MCX contain reversed-phase extraction sorbents that perform captive extraction. 
Captive extraction is where analytes of interest are trapped onto the sorbent bed, 
while interferences are removed from the sorbent bed through wash steps. The 
analytes of interests are then released from the sorbent bed with a final elution 
solvent. To reduce the extraction time, the samples are placed on a vacuum 
pressure manifold, using negative pressure to move each step  
The HLB extraction protocols consist of the following steps: 
1. Condition columns first with MeOH, then water 
2. Load 2mL of organic sample in 100mL water with a pH of 3, 7, or 10 
3. Wash sorbent bed with 2mL of a percentage of organic solvent in 
water at either pH 3 or pH 10 
4. Elute analyte from sorbent bed with 2mL of a percentage of organic 
solvent in water at either pH3 or pH 10 
The MCX extraction protocols consist of the following steps: 
1. Condition columns first with MeOH, then water 
2. Load 2mL of organic sample at pH7 
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3. Wash sorbent bed with 2mL of 0.1N HCl in water 
4. Wash sorbent bed with 2mL of organic solvent with 2% formic acid 
(pH3) 
5. Elute sample with 2mL of organic solvent with 2% ammonium 
hydroxide 
HLB PRiME cartridges also contain a reversed-phase extraction sorbent, but it 
utilizes passive extraction so that the compound of interest is eluted when the 
sample is loaded onto the cartridge. To evaluate this, samples were created in a 
percentage of organic in water, ranging from 50% to 90% organic at pH 3, 7, or 
10.  
For the SPE cartridge recovery evaluation, the loading, wash steps, and 
elution eluents for each sample were retained and analyzed using the final 
chromatographic method. The HLB, MCX, and HLB PRiME recovery 
percentages were calculated by dividing the average area count of each loading, 
wash, or elution eluents by the total area count of the sample peaks. TargetLynx 
was used to obtain the area counts of any peaks that were present. 
2.4.4 Bone and hair sample preparation prior to SPE 
 The bone preparation protocol was taken from Mella et al with no 
alterations [38]. The hair preparation protocol was adapted from Mella et al’s 
procedure to accommodate the smaller hair sample amounts collected in a 
forensic setting. In previous toxicological research with hair, the largest sample 
mass used was 100mg [9], but in the interest of ensuring the supply of drug-free 
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hair would not run out, 50mg was decided as the sample mass. The protocols 
are as featured in Table 6. 
Table 6: Bone and Hair Extraction Protocols 
Bone Extraction Protocol Hair Extraction Protocol 
1. 1g bone material and 4mL of solvent 
added to 15mL bead mill tube with 4 
4mm ceramic ball bearings and 
sealed 
1. 50mg hair material and 4mL of 
solvent added to 15mL bead mill 
tube with 4 4mm ceramic ball 
bearings and sealed 
2. Bead mill tube inserted into 
Precellys bead mill and shaken for 
three 90 second cycles at 5000rpm 
2. Bead mill tube inserted into 
Precellys bead mill and shaken for 
three 90 second cycles at 5000rpm 
3. Bead mill tube placed into centrifuge 
for 5 minutes at 3500rpm 
3. Bead mill tube placed into 
centrifuge for 5 minutes at 3500rpm 
4. Sample decanted from bead mill 
tube into centrifuge filter tube and 
placed back into centrifuge for 5 
minutes at 3500rpm 
4. Sample decanted from bead mill 
tube into centrifuge filter tube and 
placed back into centrifuge for 5 
minutes at 3500rpm 
5. SPE is performed 5. SPE is performed 
 
 Two types of centrifuge filter tubes were used in this experiment due to 
their availability: Chrom Tech® PFTE 0.45µm, Midi tubes and Sartorius 
Vivaspin® 6 tubes with a PES filter.  
2.4.5 Data processing 
 TargetLynx was used to acquire limit of detection, limit of quantitation, 
linear dynamic range, recovery, calibration curves, bias, and precision data. A 
ten-point calibration curve was run in triplicate. Samples ranged in concentration 
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from 1pg/mL to 1ng/mL, and 15pg/mL and 300pg/mL samples acted as low and 
high quality controls (QC).  
A linear calibration model with a 1/x weighting factor was used to create a 
curve to which samples could be compared. This curve also determines limit of 
detection (LOD), limit of quantitation (LOQ), percent bias, percent precision, and 
linear dynamic range (LDR). According to the Scientific Working Group for 
Forensic Toxicology, LOD is defined as “an estimate of the lowest concentration 
of an analyte in a sample that can be reliably differentiated from blank matrix and 
identified by the analytical method”[39]; from a chromatographic stand point, LOD 
is represented by lowest concentration where the signal height of the peak of 
interest is greater than 1/10th the signal height of the baseline noise. However, 
LOQ is defined as an estimate of the lowest concentration of an analyte in a 
sample that can be reliably measured with acceptable bias and precision”[39]; on 
a chromatogram, this is the lowest concentration at which the signal height of the 
peak of interest is greater than 1/3rd the height of the baseline noise. Bias refers 
to how close your data points are to the expected concentration, and precision 
refers to how close your data points are to each other for a given concentration. 
To provide a reference point, all samples were spiked with an internal standard 
mixture of Ketamin-D4 and Xylazine-D6 post extraction at a concentration of 
2ng/mL. This provides a known concentration for the calibration model to 
compare to the calibration curve samples and acts as an indicator that the 
instrumentation was functioning correctly for the duration of the run.  
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3. RESULTS AND DISCUSSION 
3.1 SPE Cartridge Evaluation 
 Out of the three SPE cartridge sorbents evaluated, HLB Prime showed the 
highest sample recovery percentage.  
 
Table 7: Percent Recovery for HLB 3cc, 60mg extraction 
 
0 10 20 30 40 50 60 70 80 90 100 
Ketamine ACN 
pH3 0.06 85.22 13.15 1.19 0.20 0.06 0.04 0.04 0.03 0.00 0.01 
Ketamine ACN 
pH10 0.12 0.12 12.54 81.45 3.90 0.68 0.35 0.28 0.17 0.18 0.21 
Ketamine MeOH 
pH3 0.16 4.61 83.98 7.70 1.58 0.82 0.44 0.29 0.19 0.22 0.00 
Ketamine MeOH 
pH10 0.05 0.12 2.76 50.84 15.74 20.33 5.17 2.74 1.05 0.80 0.41 
Xylazine ACN 
pH3 0.03 52.57 34.09 7.69 2.47 1.29 0.56 0.52 0.42 0.24 0.11 
Xylazine ACN 
pH10 0.16 0.93 1.08 60.31 25.50 5.62 2.20 1.51 0.85 0.58 1.26 
Xylazine MeOH 
pH3 0.19 1.47 78.15 10.28 3.15 2.06 1.60 0.95 1.18 0.97 0.00 
Xylazine MeOH 
pH10 0.17 0.46 0.77 26.00 12.12 24.71 12.79 12.07 5.77 3.14 1.99 
 Maximum Recovery    
 
Table 8: Percent Recovery for HLB PRiME 3cc, 60mg 
  
50 55 60 65 70 75 80 85 90 
Ketamine 
ACN pH3 95.29 93.41 94.26 92.68 90.38 92.42 92.62 90.89 88.42 
Ketamine 
ACN pH7 50.73 61.55 62.77 65.90 71.64 74.51 79.49 80.48 81.49 
Ketamine 
ACN pH10 67.87 68.29 70.48 78.37 79.14 81.96 82.12 82.84 85.07 
Ketamine 
MeOH pH3 86.84 90.71 88.44 89.45 89.09 89.09 89.68 89.97 96.53 
Ketamine 
MeOH pH7 2.98 17.78 30.98 45.67 54.08 63.25 67.93 72.62 91.80 
Ketamine 
MeOH pH10 4.15 20.25 35.98 55.01 64.81 75.92 77.60 81.92 94.14 
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  50 55 60 65 70 75 80 85 90 
Xylazine ACN 
pH3 92.11 87.99 90.60 89.51 85.63 89.55 89.31 88.45 87.45 
Xylazine ACN 
pH7 15.62 25.26 29.19 33.61 42.51 39.75 48.72 49.76 53.66 
Xylazine ACN 
pH10 28.83 31.91 37.83 53.28 51.13 56.70 57.25 55.86 56.12 
Xylazine 
MeOH pH3 79.55 85.21 82.25 85.30 85.82 84.95 86.18 87.20 95.20 
Xylazine 
MeOH pH7 0.56 12.48 13.44 23.98 28.08 35.34 32.90 36.20 68.41 
Xylazine 
MeOH pH10 1.68 12.92 23.56 38.06 56.38 63.00 72.29 72.54 92.07 
 
 
 Maximum Recovery    
 
Table 9: Percent Recovery for MCX 3cc, 60mg extraction  
 
Loading Wash 1 pH3 Wash 2 pH3 Elution pH10 
Ketamine LpH3 ACN 0.00 0.00 85.84 14.15 
Ketamine LpH7 ACN 0.04 0.02 86.03 13.91 
Ketamine LpH10 
ACN 0.28 0.02 99.70 0.00 
Ketamine LpH3 
MeOH 0.03 0.01 89.93 10.03 
Ketamine LpH7 
MeOH 0.04 0.05 86.98 12.93 
Ketamine LpH10 
MeOH 0.32 0.03 99.65 0.00 
Xylazine LpH3 ACN 0.14 0.08 88.94 10.84 
Xylazine LpH7 ACN 0.07 0.06 89.47 10.39 
Xylazine LpH10 ACN 0.25 0.02 99.73 0.00 
Xylazine LpH3 
MeOH 0.17 0.08 88.30 11.44 
Xylazine LpH7 
MeOH 0.19 0.22 84.97 14.61 
Xylazine LpH10 
MeOH 0.58 0.04 99.38 0.00 
 Maximum Recovery    
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In the initial MCX cartridge experiment, approximately 83.26% of the target 
analytes were being eluted in the second wash step (Table 9). To determine the 
cause, increasing percentages from 10% to 100% of organic solvent in water at 
5% formic acid were used to wash the cartridge, and the area counts of each 
wash sample were evaluated (Table 10).  
Table 10: Percent Recovery for MCX 3cc, 60mg cartridges, Wash 2 10-100% 
Organic Percentages 
Sample Ketamine % Recovery Xylazine % Recovery 
Loading 0.07 0.13 
W1 pH3 0.08 0.10 
W2 10% 
MeOH pH3 0.15 0.04 
W2 20% 
MeOH pH3 0.31 0.16 
W2 30% 
MeOH pH3 0.17 0.08 
W2 40% 
MeOH pH3 0.23 0.04 
W2 50% 
MeOH pH3 0.11 0.02 
W2 60% 
MeOH pH3 0.22 0.03 
W2 70% 
MeOH pH3 0.24 0.07 
W2 80% 
MeOH pH3 0.14 0.05 
W2 90% 
MeOH pH3 0.06 0.03 
W2 100% 
MeOH pH3 0.10 0.07 
Elute 100% 
MeOH 
pH10 
98.13	  	   99.20 
 Maximum Recovery    
 
In addition, a larger MCX sorbent bed size of 6cc, 150mg was evaluated (Table 
11).  
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Table 11: Percent Recovery for MCX, 6cc, 150mg solvent extraction 
 Loading Wash 1 Wash 2 Elution 
Ketamine in 
ACN 
1.69 0.19 1.15 96.97 
Ketamine in 
MeOH 
1.76 0.08 1.54 96.63 
Xylazine in 
ACN 
0.22 0.15 0.46 99.18 
Xylazine in 
MeOH 
1.90 0.45 0.39 97.25 
 Maximum Recovery    
 
While the increasing organic percentages and larger sorbent sizes for the 
MCX cartridges did produce chromatograms replicating similar results from 
previous studies, the HLB PRiME 6cc, 200mg SPE cartridges showed less 
extraneous peaks  in comparison, as seen in Figure 12. 
 
Figure 12: MCX versus HLB PRiME comparison 
38 
Table 12: Percent Recovery for HLB PRiME 6cc, 200mg extraction 
evaluation, Loading 50%MeOH pH10, Eluting 50%ACN pH3 
  Load 50%MeOH pH10 
Elute 50%ACN 
pH3 
Wash 100% ACN 
pH3 
Ketamine 
Solvent A 
- 94.82 5.18 
Ketamine 
Solvent B 
- 95.64 4.36 
Ketamine 
Solvent C 
0.68 97.71 1.61 
Ketamine 
Solvent D 
0.60 98.16 1.24 
Xylazine 
Solvent A 
- 92.82 7.18 
Xylazine 
Solvent B 
- 93.89 6.11 
Xylazine 
Solvent C 
0.35 96.85 2.80 
Xylazine 
Solvent D 
0.25 97.41 2.34 
 Maximum Recovery    
 
 
After determining the SPE cartridge, sample preparation commenced. 
While running the hair extraction calibration curves, an abnormally large 
concentration of ketamine was observed in even the lowest calibrators that had 
not been observed in the bone extractions. Two types of centrifuge filter tubes 
were used in this experiment: Chrom Tech® PFTE 0.45μm, Midi tubes and 
Sartorius Vivaspin® 6 tubes with a PES filter. The bone extractions were 
performed with the Chrom Tech® tubes, and the hair extractions were performed 
with the Vivaspin® tubes. Blank hair extracted with the Vivaspin® tubes showed 
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an approximate e7 signal for ketamine’s 125.1 quantitation ion, as shown in 
Figure 13.  
 
 
Figure 13: Chrom Tech® and Vivaspin® Contamination Comparison 
 
 
This may be due to the PES filter or the plastic material of the tube itself. Thus 
solvent extractions were performed to evaluate LOD, LOQ, accuracy, bias and 
precision. 
3.2 Solvent Extraction Calibration 
 The linear dynamic range is determined to be 2pg/mL-1ng/mL for xylazine 
and 5pg/mL-1ng/mL for ketamine. The LOD and LOQ values are 2pg/mL for 
xylazine and 5pg/mL for ketamine. These numbers were determined by 
evaluating the three calibration curves and determining the ranges that achieved 
r2 values of 0.98 or better, as per SWGTOX guidelines and can be seen in 
Figures 14 and 15. 
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Figure 14: Xylazine Solvent Extraction, Calibration Curves 1-3, r2=0.998 
 
 
Figure 15: Ketamine Solvent Extraction, Calibration Curves 1-3, r2=0.998 
 
Both the ketamine and xylazine curves have r2 values of 0.998. Those values fit 
the curve by maintaining a line of best fit within ±20% percent for accuracy and 
precision. 
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4. CONCLUSIONS  
 This research focused on developing an efficient method for detection of 
ketamine and xylazine in rat fur and bone samples following a six-month outdoor 
exposure period, in order to mimic forensic casework involving bones and hair. 
Current methods are time-consuming, so reducing extraction and evaluation 
times would increase case outputs in forensic labs while reducing the amount of 
sample and consumables required. Multidimensional chromatography reduces 
preparation times by eliminating the drying down and reconstitution of samples, 
which can take hours as opposed to half an hour total extraction time shown in 
this study.  The opioid epidemic has increased the amount of forensic casework, 
including toxicological samples. With these reduced preparation times, forensic 
toxicology labs will be able to efficiently process their samples without sacrificing 
sensitivity. 
In developing the extraction method, HLB PRiME, a different SPE sorbent 
bed chemistry, produced equivalent recovery percentages and signal strengths 
with improved peak shape when compared to the MCX cartridges used in 
previous studies. This opens up additional avenues of exploration for different 
analytes of interest that may respond better to the HLB PRiME sorbent    
Using a solvent extraction, the linear dynamic ranges of both ketamine 
and xylazine were established to be 5pg/mL-1ng/mL and 2pg/mL-1ng/mL in both 
LOD and LOQ, which indicates a sensitivity suitable for quantitation down to 
trace levels of detection. 
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5. FUTURE DIRECTIONS 
 
This study has opened up new avenues of exploration for forensic 
toxicology. Now that HLB PRiME has proven to be a suitable SPE sorbent for 
multidimensional chromatography, this increases the range of drugs that can be 
analyzed using this method. Because designer drugs are appearing in an 
increasing number of forensic cases, having multiple SPE options increases the 
likelihood that they will be detectable using multidimensional chromatography. 
In addition, future analysis of unknown samples will assist in the 
development of forensic methods. The Chrom Tech® tubes were effective in 
removing physical contaminants without introducing new ones, so they should be 
used going forward.  The bone and fur samples utilized here will provide case 
analogs with known dosages for comparison. In addition to postmortem 
toxicology, DFSA cases would be another case type where multidimensional 
chromatography would prove useful. The process of incorporating drugs into hair 
results in detection at least three weeks post-exposure, which means victims who 
report after the window for analysis via blood and urine has closed may still have 
toxicological evidence that can be non-invasively collected. 
The use of nontraditional matrices can also be incorporated into drug 
chemistry cases. More states are legalizing the use of marijuana for both medical 
and recreational uses, leading to an increased presence of tetrahydrocannabinol, 
its metabolites, and its analogs in casework, not just in plant form, but in oil and 
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edible formulations. The efficient preparation and extraction processes utilized in 
this study can be applied to analyzing those samples with the same sensitivity. 
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